The deletion polymorphism of the angiotensin I-converting enzyme gene is associated with target organ damage in essential hypertension

Journal of the American Society of Nephrology

Volumn 7, Issue 12, 1996, Pages 2550-2558

  Pontremoli, Roberto ^a   Sofia, Antonella ^a   Tirotta, Angelito ^a   Ravera, Maura ^a   Nicolella, Clizia ^a   Viazzi, Francesca ^a   Bezante, Gian Paolo ^a   Borgia, Luigi ^b   Bobola, Nicoletta ^b   Ravazzolo, Roberto ^b   Sacchi, Giorgio ^c   Deferrari, Giacomo ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF URBINO   (Italy)

Author keywords

ACE gene polymorphism; Left ventricular hypertrophy; Microalbuminuria; Renin angiotensin aldosterone system; Retinopathy

Indexed keywords

ALBUMIN; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; ARTICLE; ESSENTIAL HYPERTENSION; FEMALE; GENE DELETION; GENETIC POLYMORPHISM; GENOTYPE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PRIORITY JOURNAL; RETINOPATHY; RISK FACTOR;

EID: 9844237575     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Laragh JH: Renin profiling for diagnosis, risk assessment, and treatment of hypertension. Kidney Int 1993; 44:1163-1175.
2. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F: An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86:1343-1346.
3. Tiret L, Brigitte R, Visvikis S, et al.: Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992;51: 197-205.
4. Schunkert H, Hense HW, Holmer SR, et al.: Association between a deletion polymorphism of the angiotensin converting enzyme gene and left ventricular hypertrophy. N Engl J Med 1994;330:1634-1638.
5. Iwai N, Ohmichi N, Nakamura Y, Kinoshita M: DD genotype of the angiotensin converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation 1994;90:2622-2628.
6. Cambien F, Poirier O, Lecerf L, et al.: Deletion polymorphism in the gene for angiotensin converting enzyme is a potent risk factor for myocardial infarction. Nature (Lond) 1992;359:641-644.
7. Nakai K, Itoh C, Miura Y, et al.: Deletion polymorphism of the angiotensin-I converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. Circulation 1994;90:2199-2202.
8. Ruiz J, Blanché H, Cohen N, et al.: Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin dependent diabetes mellitus. Proc Natl Acad Sci USA 1994;91:3662-3665.
9. Lindpaintner K, Pfeffer MA, Kreutz R, et al.: A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995;332:706-711.
10. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
11. Rigat B, Hubert C, Corvol P, Soubrier F: PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP 1) (dipeptidylcarboxypeptidase 1). Nucleic Acids Res 1992;20:1443.
12. Mangili R, Deferrari G, Di Mario U, et al.: Prevalence of hypertension and microalbuminuria in adult type 1 (insulin dependent) diabetic patients without renal failure in Italy: Validation of screening techniques to detect albuminuria. Acta Diabetol 1992;29:156-166.
13. Keith NM, Wagener HP, Barker MW: Some different types of essential hypertension: Their course and prognosis. Am J Med Sci 197;1939.332-343.
14. Sahn DJ, De Maria A, Kisslo J, Weyman A: Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072-1083.
15. Schiller NB, Shah PM, Crawford M, et al.: Recommendations for quantitation of the left ventricle by two dimensional echocardiography: American Society of Echocardiography Committees. J Am Soc Echo 1989;55: 358-367.
16. Devereux RB, Reichek N: Echocardiographic determination of left ventricular mass in man: Anatomic validation of the method. Circulation 1977;55:613-618.
17. Devereux RB: Detection of left ventricular hypertrophy by M-mode echo-cardiography: Anatomic validation, standardization, and comparison to other methods. Hypertension 1987;9[Suppl II]: 19-26.
18. Weisberg S. Applied Linear Regression. New York: Wiley; 1980.
19. Tryon RC, Bailey DE. Cluster Analysis. New York: McGraw-Hill; 1970.
20. Harrap SB, Davidson HR, Connor JM, et al.: The angiotensin I converting enzyme gene and predisposition to high blood pressure. Hypertension 1993;21:455-460.
21. Morris BJ, Zee RYL, Schrader AP: Different frequencies of angiotensin-converting enzyme genotypes in older hypertensive individuals. J Clin Invest 1994;94:1085-1089.
22. Raynolds MV, Bristow MR, Bush EW, et al.: Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy. Lancet 1993;342:1073-1075.
23. Hamogouchi A, Yoshida H, Miyazaki Y, Kawamura T, Mitarai T, Sakai O: The deletion polymorphism of the ACE gene is a risk factor for the progression to renal failure independent of the M2357 polymorphism in the angiotensinogen gene [Abstract]. J Am Soc Nephrol 1995;6:389A.
24. Yoshida H, Mitari T, Kawamura T, et al.: Role of the deletion polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J Clin Invest 1995;96: 2162-2169.
25. Alderman MH, Madhavan S, Ooi WL, Cohen H, Sealy JE, Laragh JH: Association of the renin sodium profile with the risk of miocardial infarction in patients with hypertension. N Engl J Med 1991;324:1098-1104.
26. Ritz E, Nowicki M, Fliser D, Horner D, Klimm HP: Proteinuria and hypertension. Kidney Int 1994;46[Suppl 47]:S76-S80.
27. Biesenbach G, Zazgornik J: High prevalence of hypertensive retinopathy and coronary heart disease in hypertensive patients with persistent microalbuminuria under short intensive antihypertensive therapy. Clin Nephrol 1994;41:211-218.
28. Savage DD, Drayer JIM, Henry WL, et al.: Echocardiographic assessment of cardiac anatomy and function in hypertensive subjects. Circulation 1979;59:623-632.
29. Cerasola G, Cottone S D'Ignoto G, et al.: Microalbuminuria as a predictor of cardiovascular damage in essential hypertension. J Hypertens 1989;7[Suppl 6]:S332-S333.
30. Schouten EG, Vandenbroucke JP, Van Der HeideWessel C, Van Der Heide RM: Retinopathy as an independent indicator of all-causes mortality. Int J Epidemiol 1986;15:234-236.
31. Kannel WB, Gordon T, Castelli WP, Margolis JR: Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease: The Framingham Study. Ann Intern Med 1970;72:813-822.
32. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP: Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990;322:1561-1566.
33. Sullivan JM, Vander Zwaag R, el-Zeky F, Ramanathan KB, Mirvis DM: Left ventricular hypertrophy: Effect on survival. J Am Coll Cardiol 1993;22:508-513.
34. Levy D, Anderson KM, Savage DD, Kannel WB, Christiansen JC, Castelli WP: Echocardiographically detected left ventricular hypertrophy-prevalence and risk factors: The Framingham Heart Study. Ann Intern Med 1988;108:7-13.
35. Grossman W, Jones D, McLaurin LP: Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest 1975;56:56-64.
36. Ganau A, Devereux RP, Pickering TG, et al.: Relation of left ventricular hemodynamic load and contractile performance to left ventricular mass in hypertension. Circulation 1990;81:25-36.
37. Devereux RB: Echocardiographic insights into the pathophysiology and prognostic significance of hypertensive cardiac hypertrophy. Am J Hypertens 1989;2: 186S-195S.
38. Lindpainter K, Lee M, Larson MG, et al.: Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass. N Engl J Med 1996;334:1023-1028.
39. Yudkin JS, Forrest RD, Jackson C: Microalbuminuria as predictor of vascular disease in nondiabetic subjects. Lancet 1988;2:530-533.
40. Samuelsson O, Wilhelmsen L, Elmfeldt D, et al.: Predictors of cardiovascular morbidity in treated hypertension: Results from the primary preventive trial in Göteborg, Sweden. J Hypertens 1985;3:167-176.
41. Schmiedr R, Grube E, Ruddel H, Schlebush H, Schulte W: Microproteinuria as a marker for target organ damage in essential hypertension. Klin Wochenschr 1990;68: 256-259.
42. Khairallah PA, Kanabus J: Angiotensin and myocardial protein synthesis. Perspect Cardiovasc Res 1983;8:337-347.
43. Katz AM: Angiotensin II: Hemodynamic regulator or growth factor? J Mol Cell Cardiol 1990;22:739-747.
44. 1 receptor subtype. Circ Res 1993;73:413-423.
45. Farhy RD, Ho KL, Carretero OA, Scicli AG: Kinins mediate the antiproliferative effect of ramipril in rat carotid artery. Biochem Biophys Res Commun 1992; 182:283-288.
46. Schunkert H, Dzau VJ, Tang SS, Hirsch AT, Apstein CS, Lorell BH: Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy: Effects on coronary resistance, contractility and relaxation. J Clin Invest 1990;86:1913-1920.
47. Costerousse O, Allegrini J, Lopez M, Alhenc-Gelas F: Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem J 1993;290:33-40.
48. Schunkert H, Jackson B, Tang SS, et al.: Distribution and functional significance of cardiac angiotensin converting enzyme in hypertrophied rat hearts. Circulation 1993;87:1328-1339.
49. Studer R, Reinecke H, Muller B, Holtz J, Just H, Drexler H: Increased angiotensin I converting enzyme gene expression in the failing human heart: Quantification by competitive RNA-polymerase chain reaction. J Clin Invest 1994;94:301-310.
50. Villarreal FJ, Kim NN, Ungab GD, Printz MP, Dillmann WH: Identification of functional angiotensin II receptors on rat cardiac fibroblasts. Circulation 1993;88:2849-2861.
51. Schelling P, Fischer H, Ganten D: Angiotensin and cell growth: A link to cardiovascular hypertrophy? J Hypertens 1991;9:3-15.
52. Malik KU, Nasjletti A: Facilitation of adrenergic transmission by locally generated angiotensin II in rat mesenteric arteries. Circ Res 1976;38:26-30.
53. Erley CM, Holzer M, Kramer BK, Risler T: Renal haemodynamics and organ damage in young hypertensive patients with different plasma renin activities after ACE inhibition. Nephrol Dial Transplant 1992;7:216-220.
54. Liebson PR, Grandits G, Prineas R, et al.: Echocardiographic correlates of left ventricular structure among 844 mildly hypertensive men and women in the treatment of mild hypertension study (TOMHS). Circulation 1993;87:476-486.